Results 211 to 220 of about 7,402 (232)
Some of the next articles are maybe not open access.

Personalizing Oncolytic Virotherapy

Human Gene Therapy, 2023
The use of oncolytic viruses has become an attractive tool in the clinics for the treatment of various tumor types. Such viruses are genetically modified to conditionally replicate in malignant cells while unharming healthy cells. This platform offers a highly specific tumor killing with exceptional safety profiles.
Firas Hamdan   +2 more
openaire   +2 more sources

What is oncolytic virotherapy? [PDF]

open access: possibleArchives of disease in childhood - Education & practice edition, 2017
It has long been hypothesised that viruses may have a role in treating cancer. From the mid-1800s, there has been documentation of patients undergoing spontaneous cancer remission following severe infection, and by the start of the 20th century, a temporary complete remission of acute leukaemia was observed in a patient suffering from influenza.1 Over ...
Julia V. Cockle, Karen Scott
openaire   +2 more sources

Oncolytic virotherapy as immunotherapy

Science, 2021
Recognizing immune responses to oncolytic virotherapy opens the way for new ...
Alan, Melcher   +2 more
openaire   +2 more sources

Oncolytic Virotherapy

Journal of Vascular and Interventional Radiology, 2013
Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral ...
Steven C. Rose   +2 more
openaire   +3 more sources

Poxvirus oncolytic virotherapy

Expert Opinion on Biological Therapy, 2019
Over the last decade, advances in biological therapies have resulted in remarkable clinical responses for the treatment of some previously incurable cancers. Oncolytic virotherapy is one of these promising novel strategies for cancer therapy. A successful oncolytic virus promotes tumor cell oncolysis and elicits a robust long-term anti-tumor immunity ...
Lino E. Torres-Dominguez, Grant McFadden
openaire   +3 more sources

Oncolytic virotherapy: Challenges and solutions

Current Problems in Cancer, 2021
Viruses as cancer therapies have attracted attention since the 19th century. Scientists observation that viruses can preferentially lyse cancer cells rather than healthy cells, created the field of oncolytic virology. Like other therapeutic strategies, oncolytic virotherapy has challenges, such as penetration into tumor bulk, anti-viral immune ...
Nasser Hashemi Goradel   +5 more
openaire   +3 more sources

Oncolytic Virotherapy by HSV

2018
Oncolytic virotherapy is a kind of antitumor therapy using viruses with natural or engineered tumor-selective replication to intentionally infect and kill tumor cells. An early clinical trial has been performed in the 1950s using wild-type and non-engineered in vitro-passaged virus strains and vaccine strains (first generation oncolytic viruses ...
Fumi Goshima, Daisuke Watanabe
openaire   +2 more sources

Oncolytic virotherapies for pediatric tumors

Expert Opinion on Biological Therapy, 2023
Many pediatric patients with malignant tumors continue to suffer poor outcomes. The current standard of care includes maximum safe surgical resection followed by chemotherapy and radiation which may be associated with considerable long-term morbidity.
Evan G Gross   +6 more
openaire   +2 more sources

Introduction to Oncolytic Virotherapy

2019
Oncolytic viruses exploit key hallmarks of cancer for replication in malignant cells, leading to tumor cell lysis, modulation of the tumor microenvironment and in situ vaccination effects. Diverse virus platforms have been developed as oncolytic vectors and designed for improved tumor specificity, intratumoral spread, therapeutic gene delivery and ...
John C. Bell   +2 more
openaire   +2 more sources

Oncolytic virotherapy for multiple myeloma

Expert Opinion on Biological Therapy, 2008
Current therapies for multiple myeloma (MM) are not curative, thus novel targeted therapeutics are being developed. One such targeted therapy is oncolytic virotherapy, wherein viruses specifically infect and kill the malignant plasma cells, leaving normal cells intact.This review provides an overview of the mechanisms and results of the oncolytic ...
Amaalia E Stief, J. Andrea McCart
openaire   +3 more sources

Home - About - Disclaimer - Privacy